Parquest Capital
Parquest Capital describes itself as an independent French private equity firm dedicated to investing in French SMEs. Its stated model includes majority and minority investments, family-business transmissions, MBOs, acquisitions of non-strategic industrial subsidiaries and equity strengthening.
Parquest Capital publicly targets French SMEs valued between €20M and €200M.
Parquest III can invest up to €100m per transaction, both directly and through its investors.[1][2][3][5][6][7][8][11]
What does Parquest Capital invest in?
Parquest Capital describes itself as an independent French private equity firm dedicated to investing in French SMEs. It specializes in the mid-market segment and states that it prioritizes projects that can prosper with its support.
Parquest’s legal notice identifies the firm as a société par actions simplifiée and as a portfolio management company authorized by the French Autorité des marchés financiers under number GP02-021. The notice states that its website is intended exclusively for professional or assimilated clients.[1][2][10]
Parquest publicly lists family-business transmissions, primary and secondary MBOs, acquisitions of non-strategic industrial subsidiaries and equity strengthening among its investment situations. Its stated approach includes investing alongside management teams and supporting entrepreneurial projects.
Parquest states that ESG is integrated into investment decisions and that portfolio companies are supported before investment, during the holding phase and through exit.[1][11]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Parquest Capital?
An owner evaluating Parquest should compare the proposed transaction with the firm’s disclosed French SME focus, stated €20M–€200M valuation range, majority and minority investment model, and listed transaction situations. The owner should also clarify how ESG considerations would be reflected in the investment and operating arrangements, given Parquest’s stated ESG approach.
Key commercial points to clarify include the proposed ownership percentage, governance rights, investing vehicle, investment horizon, exit approach, follow-on acquisition capital, management-equity arrangements, financing expectations, transaction costs, exclusivity terms and any seller rollover requirements.[1][5][11]
What ownership percentage and governance rights would Parquest seek
Which fund or investment vehicle would invest
What is the expected investment horizon and exit approach
What companies does Parquest Capital target?
Parquest states that its strategy revolves around investing in French SMEs valued between €20M and €200M. Parquest III can invest up to €100m per transaction, both directly and through its investors.
Parquest’s official corporate overview does not state a universal minimum EBITDA, revenue or profitability threshold. That statement is limited to the official corporate overview identified in the source.[1][5]
Parquest’s current preferred sectors are B2B services, software, and Health & Care. Its corporate sector materials also identify consumer goods among its preferred investment sectors.[3][4]
Parquest states that it invests in French SMEs and supports development in France and internationally.[1]
Parquest publicly describes majority and minority investments, MBOs, family-business transmissions, acquisitions of non-strategic industrial subsidiaries and equity strengthening. The sources available for this profile do not establish how Parquest classifies platform investments versus add-on investments.[1]
Official announcements identify Parquest’s minority investment in Betem Groupe alongside management on November 18, 2025, and its investment in Spectrum Groupe alongside the management team on September 4, 2025. The Betem announcement states that the company had 450 employees and €55M in revenue; the Spectrum announcement reports €32M in 2024 revenue and around 120 employees.
The official Parquest portfolio page identifies preferred sectors but does not display an itemized current portfolio company list.[3][6][7]
Parquest announced the sale of Aserti to Chequers Capital alongside management on March 20, 2026; Parquest had been Aserti’s majority shareholder since 2017. It acquired a minority stake in Betem Groupe alongside management on November 18, 2025, and invested in Spectrum Groupe alongside its management team on September 4, 2025.
On July 8, 2025, Parquest agreed terms on the sale of Sopral to Inspired Pet Nutrition, controlled by CapVest. The announcement described the transaction as an agreed sale, and stated that financial terms were not disclosed.[6][7][8][9]
What is not clear from Parquest Capital's public investment criteria?
The official Parquest portfolio page identifies preferred sectors but does not display an itemized current portfolio company list.
The Betem Groupe, Spectrum Groupe and Sopral announcements each state that financial terms were not disclosed. Parquest’s official corporate overview does not state a universal minimum EBITDA, revenue or profitability threshold, and the official investment-strategy and transaction pages do not state a universal expected ownership duration or standard exit timetable.[1][3][5][6][7][8]
Questions to ask when evaluating Parquest Capital as a buyer or investment partner
What ownership percentage and governance rights would Parquest seek?
Which fund or investment vehicle would invest?
What is the expected investment horizon and exit approach?
What minimum EBITDA, revenue, profitability or growth criteria apply beyond the published €20M–€200M valuation range?
How much capital is available for follow-on acquisitions and other growth initiatives?
How would ESG objectives be incorporated into the investment agreement and operating plan?
Sources & research notes
- Official website / firm overview
- Investment strategy
- Industry / market focus
- Industry / market focus
- Transaction size / criteria
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
- Investment approach
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.
